Final Size for Epidemic Models with Asymptomatic Transmission
The final infection size is defined as the total number of individuals that become infected throughout an epidemic. Despite its importance for predicting the fraction of the population that will end infected, it does not capture which part of the infected population will present symptoms. Knowing th...
| Autores: | , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2023 |
| País: | España |
| Recursos: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:282877 |
| Acesso em linha: | https://ddd.uab.cat/record/282877 https://dx.doi.org/urn:doi:10.1007/s11538-023-01159-y |
| Access Level: | acceso abierto |
| Palavra-chave: | Final infection size Symptomatic population Reproduction number |
| id |
ES_6d64f222186baef836e0df0eb8d89ee7 |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:282877 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Final Size for Epidemic Models with Asymptomatic TransmissionBarril, Carles|||0000-0002-4612-5533Bliman, Pierre-AlexandreCuadrado Gavilán, Sílvia|||0000-0003-2051-2030Final infection sizeSymptomatic populationReproduction numberThe final infection size is defined as the total number of individuals that become infected throughout an epidemic. Despite its importance for predicting the fraction of the population that will end infected, it does not capture which part of the infected population will present symptoms. Knowing this information is relevant because it is related to the severity of the epidemics. The objective of this work is to give a formula for the total number of symptomatic cases throughout an epidemic. Specifically, we focus on different types of structured SIR epidemic models (in which infected individuals can possibly become symptomatic before recovering), and we compute the accumulated number of symptomatic cases when time goes to infinity using a probabilistic approach. The methodology behind the strategy we follow is relatively independent of the details of the model. 22023-01-0120232023-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/282877https://dx.doi.org/urn:doi:10.1007/s11538-023-01159-yreponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengAgencia Estatal de Investigación https://doi.org/10.13039/501100011033 PID2021-123733NB-I00Agència de Gestió d'Ajuts Universitaris i de Recerca https://doi.org/10.13039/501100003030 2021/SGR-00113open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2828772026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
Final Size for Epidemic Models with Asymptomatic Transmission |
| title |
Final Size for Epidemic Models with Asymptomatic Transmission |
| spellingShingle |
Final Size for Epidemic Models with Asymptomatic Transmission Barril, Carles|||0000-0002-4612-5533 Final infection size Symptomatic population Reproduction number |
| title_short |
Final Size for Epidemic Models with Asymptomatic Transmission |
| title_full |
Final Size for Epidemic Models with Asymptomatic Transmission |
| title_fullStr |
Final Size for Epidemic Models with Asymptomatic Transmission |
| title_full_unstemmed |
Final Size for Epidemic Models with Asymptomatic Transmission |
| title_sort |
Final Size for Epidemic Models with Asymptomatic Transmission |
| dc.creator.none.fl_str_mv |
Barril, Carles|||0000-0002-4612-5533 Bliman, Pierre-Alexandre Cuadrado Gavilán, Sílvia|||0000-0003-2051-2030 |
| author |
Barril, Carles|||0000-0002-4612-5533 |
| author_facet |
Barril, Carles|||0000-0002-4612-5533 Bliman, Pierre-Alexandre Cuadrado Gavilán, Sílvia|||0000-0003-2051-2030 |
| author_role |
author |
| author2 |
Bliman, Pierre-Alexandre Cuadrado Gavilán, Sílvia|||0000-0003-2051-2030 |
| author2_role |
author author |
| dc.subject.none.fl_str_mv |
Final infection size Symptomatic population Reproduction number |
| topic |
Final infection size Symptomatic population Reproduction number |
| description |
The final infection size is defined as the total number of individuals that become infected throughout an epidemic. Despite its importance for predicting the fraction of the population that will end infected, it does not capture which part of the infected population will present symptoms. Knowing this information is relevant because it is related to the severity of the epidemics. The objective of this work is to give a formula for the total number of symptomatic cases throughout an epidemic. Specifically, we focus on different types of structured SIR epidemic models (in which infected individuals can possibly become symptomatic before recovering), and we compute the accumulated number of symptomatic cases when time goes to infinity using a probabilistic approach. The methodology behind the strategy we follow is relatively independent of the details of the model. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2 2023-01-01 2023 2023-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/282877 https://dx.doi.org/urn:doi:10.1007/s11538-023-01159-y |
| url |
https://ddd.uab.cat/record/282877 https://dx.doi.org/urn:doi:10.1007/s11538-023-01159-y |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.relation.none.fl_str_mv |
Agencia Estatal de Investigación https://doi.org/10.13039/501100011033 PID2021-123733NB-I00 Agència de Gestió d'Ajuts Universitaris i de Recerca https://doi.org/10.13039/501100003030 2021/SGR-00113 |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869410349013270528 |
| score |
15,300719 |